Thyroid Dysfunction Impact in Patients With Metastatic Melanoma Treated With Anti–PD-1 Antibodies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prognostic Impact of Thyroid Dysfunctions on Progression-Free Survival in Patients With Metastatic Melanoma Treated With Anti-PD-1 Antibodies
Melanoma Res. 2021 Jun 01;31(3)208-217, A Frelau, E Jali, B Campillo-Gimenez, M Pracht, M Porneuf, M Dinulescu, J Edeline, L Boussemart, T LesimpleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.